Cargando…
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
Neurofibromin 1 (NF1), a tumor suppressor that negatively regulates RAS through its GTPase activity, is highly mutated in various types of sporadic human cancers, including melanoma. However, the binding partners of NF1 and the pathways in which it is involved in melanoma have not been characterized...
Autores principales: | Alon, Michal, Arafeh, Rand, Lee, Joo Sang, Madan, Sanna, Kalaora, Shelly, Nagler, Adi, Abgarian, Tereza, Greenberg, Polina, Ruppin, Eytan, Samuels, Yardena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101293/ https://www.ncbi.nlm.nih.gov/pubmed/30131853 http://dx.doi.org/10.18632/oncotarget.25805 |
Ejemplares similares
-
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
por: Alon, Michal, et al.
Publicado: (2019) -
A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS‐mutant melanoma
por: Nagler, Adi, et al.
Publicado: (2019) -
NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membrane
por: Yakovian, Oren, et al.
Publicado: (2022) -
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
por: Kalaora, Shelly, et al.
Publicado: (2020) -
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)